XDH and hyperuricemia: ULT with a xanthine oxidase inhibitor should be considered as a therapeutic option in patients at high renal risk and/or declining renal function with hyperuricemia with and without deposition, even if additional studies are needed to identify threshold values for treatment and treatment targets.